SyntekaBio Inc
KOSDAQ:226330
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
SyntekaBio Inc
KOSDAQ:226330
|
KR |
|
First Community Corp (Tennessee)
OTC:FCCT
|
US |
|
First Acceptance Corp
OTC:FACO
|
US |
|
Ester Industries Ltd
NSE:ESTER
|
IN |
|
Minco Capital Corp
XTSX:MMM
|
CA |
|
H
|
Hydrotek PCL
SET:HYDRO
|
TH |
|
S
|
Summit Royalties Ltd
XTSX:SUM
|
CA |
|
Aclarion Inc
F:IT20
|
US |
|
Queensland Pacific Metals Ltd
F:4EA
|
AU |
|
R
|
R C M Technologies Inc
XBER:RC2
|
US |
|
T
|
Taiwan Chi Cheng Enterprise Co Ltd
TPEX:3095
|
TW |
|
Ocuphire Pharma Inc
NASDAQ:OCUP
|
US |
|
Maschinenfabrik Berthold Hermle AG
F:MBH3
|
DE |
|
Z
|
Zenithtek Inc
TPEX:7912
|
TW |
|
Y
|
Yaan Enterprises Ltd
BSE:538521
|
IN |
|
Vitality Prime Inc
OTC:VPIM
|
US |
|
Elinoil Hellenic Petroleum Company SA
F:EL7
|
GR |
|
M
|
Magnitude International Ltd
NASDAQ:MAGH
|
SG |
|
S
|
SK Securities No.9 Special Purpose Acquisition Company Co Ltd
KOSDAQ:455910
|
KR |
|
Allied Security Innovations Inc
OTC:ADSV
|
US |
|
Armanino Foods Of Distinction Inc
OTC:AMNF
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SyntekaBio Inc's stock price target?
Not Available
SyntekaBio Inc does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for SyntekaBio Inc?
Projected CAGR
340%
Over the last 7 years, the compound annual growth rate for Revenue has been 43%. The projected CAGR for the next 1 year is 340%.